Takaoka and colleagues [4] identified p53 as a type I IFN transcriptional target and demonstrated the existence of a crosstalk between p53 and the IFN pathway both in tumor suppression and antiviral defense [4]. This evidence concerns the gene TP53 and neoplasm.